Add/Adhd Diagnosis & Treatment is categorized under Internal Medicine Doctors in Seattle, WA and active since 2001.
Add/Adhd Diagnosis & Treatment was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sue M Wood at the company’s single location by writing to 2150 North 107th St # 200, Seattle, Washington WA 98133 or by phoning (206) 362-4141. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Add/Adhd Diagnosis & Treatment |
Contact Person: | Sue M Wood |
Address: | 2150 North 107th St # 200, Seattle, Washington 98133 |
Phone Number: | (206) 362-4141 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Add/Adhd Diagnosis & Treatment was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Sue M Wood for inquiries that concern Add/Adhd Diagnosis & Treatment by calling the company number (206) 362-4141, as your correspondence is most welcome. Additionally, the physical location of the single location of Add/Adhd Diagnosis & Treatment can be found at the coordinates 47.706893,-122.33265 as well as the street address 2150 North 107th St # 200 in Seattle, Washington 98133.
For its online presence, you may visit Add/Adhd Diagnosis & Treatment’s website at and engage with its social media outlets through on Twitter and on Facebook.